Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Study to evaluate the safety and tolerability of MC-1101, a potential topical treatment for
non-edxudative age Related Macular Degeneration (AMD) in medically stable individuals.